pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 4·1 min read
save

Study highlights gaps in male puberty research and links timing to future health risks

Jun 4, 2026·read at STAT ↗Neutral

Researchers note that most knowledge about puberty comes from studies in girls, leaving a substantial gap in understanding how the onset of puberty in boys affects later health.

Emerging evidence suggests that the age at which boys enter puberty may be linked to a range of long‑term conditions. Early onset (before age 8) and late onset (after age 13) have both been associated with distinct health outcomes in females, and scientists now suspect similar patterns could exist for males.

In females, early puberty has been tied to higher rates of type 2 diabetes, heart disease, certain cancers and mental‑health disorders, while delayed puberty is linked to issues such as asthma and sleep problems. Researchers propose that hormonal exposure duration may drive these risks, a hypothesis they aim to test in boys.

The article calls for more focused studies on male puberty to determine whether timing serves as a predictive marker for diseases, which could eventually inform prevention strategies and therapeutic development.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Male puberty is understudied — but when it starts may predict long-term health risks”

read at STAT ↗
2,068 words · retrieved Jun 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING3PATHUNIQUE
drugs
Type 2 Diabetes4Bio TObesityTestimVogelxotestosterone
topics
Type 2 Diabetes11Cardiology8Oncology8Psychiatry & CNS5Major Depression4Asthma3Breast Cancer3Endocrinology & Metabolism3Atopic DermatitisDermatologyNeurologyObesityOrthopedicsProstate CancerUrology

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 12Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive
  • 8h agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Jul 18Opinion: Beware the unintended consequences of testosterone screening for military servicemembersSTAT